Mark Blagden

3k citations
14 papers · 2.4k · 1 hit paper · h-index 11

Impact in

Papers in

Mark Blagden

14 papers receiving 2.3k citations

Mark Blagden's Hit Papers

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 2018 · 1.4k citations
1.4k0+2+5Years since publication4008001.2k

Peers

Mark Blagden
Comparison fields: 5 of 80
  • Endocrinology, Diabetes and Metabolism 1.6k
  • Nephrology 134
  • Cardiology and Cardiovascular Medicine 320
  • Orthopedics and Sports Medicine 115
  • Anesthesiology and Pain Medicine 62
Replace Graham Ellis with:
Graham Ellis South Africa
Przemysław Borowy Poland
Nikolay Petrov Botushanov Bulgaria
Barbara Buday Hungary
Vijayaraman Arutchelvam United Kingdom
Masha Jean Livhits United States
Shih‐Chen Tung Taiwan
Enikő Kulcsár Hungary
Robert F. Kushner United States
Katalin Bezzegh Hungary
Mark Blagden relative to Graham Ellis South Africa Graham Ellis's profile →
Citations per field
00.5×5×10×15×20.7×
Graham Ellis · 1×
Citations per year

Countries citing papers authored by Mark Blagden

Since Specialization
Citations

This map shows the geographic impact of Mark Blagden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Blagden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Blagden more than expected).

Fields of papers citing papers by Mark Blagden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Blagden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Blagden. The network helps show where Mark Blagden may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Blagden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Blagden Line = papers co-authored together Mark Blagden links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Hit paper breakdown →
20181445
2 2017248
3 2018199
4 2019160
5 2020120
6 201065
7 200233
8 201630
9 201429
10 200725
11 200214
12 20108
13 20226
14 20154

About Mark Blagden

Mark Blagden is a scholar working on Endocrinology, Diabetes and Metabolism, Anesthesiology and Pain Medicine, Orthopedics and Sports Medicine, Public Health, Environmental and Occupational Health and Surgery, having authored 14 papers that have together received 2.4k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (3 papers), Lipoproteins and Cardiovascular Health (3 papers), Bone health and osteoporosis research (2 papers), Opioid Use Disorder Treatment (2 papers), Pain Management and Opioid Use (2 papers), Streptococcal Infections and Treatments (1 paper), Inflammatory mediators and NSAID effects (1 paper) and Otolaryngology and Infectious Diseases (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Nephrology (134 citations), Cardiology and Cardiovascular Medicine (320 citations), Orthopedics and Sports Medicine (115 citations) and Anesthesiology and Pain Medicine (62 citations). Mark Blagden has collaborated with scholars based in United Kingdom, Germany and Switzerland. Frequent co-authors include Michael Hopp, Edward J. Czerwinski, Kerry Palmer, Eugene Vincent McCloskey, Bernard Cortet, Robert Kees Stad, James O’Kelly, Peyman Hadji, Juraj Payer and Socrates E. Papapoulos. Their work appears in journals such as The Lancet, International Journal of Clinical Practice, Canadian Journal of Cardiology, Diabetes Care and Expert Opinion on Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact